Ascidian Therapeutics
Geraldine Hegarty currently serves as the Director, Controller at Ascidian Therapeutics since September 2023. Prior to this role, Geraldine worked at CrossCountry Consulting from November 2017 to September 2023 as an Associate Director, providing accounting advisory services to emerging growth companies. Geraldine has over nine years of experience in audit and advisory services for both public and private entities, with proficiency in various platforms including QuickBooks, Intacct, and NetSuite. Previous positions include Managing Consultant and Senior Consultant at PwC Ireland from October 2014 to October 2017, where Geraldine completed a graduate training contract and earned the Chartered Accountant qualification in August 2016. Geraldine's career began with an internship at Deloitte Ireland from September 2011 to May 2012. Academic credentials include a Master’s Degree in Accounting from UCD Michael Smurfit Graduate Business School and a Bachelor’s Degree in Business/Commerce from University College Dublin.
Ascidian Therapeutics
2 followers
Gene therapy is entering a new era as the field moves forward. But current technologies cannot overcome the challenges of many diseases. Ascidian’s unique approach aims to unlock these doors and enable treatment for millions of patients worldwide.